rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Marshall A. Hayward

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, Jupiter Neurosciences.

Every Form 4 they filed

In numbers

Trades disclosed
14
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
2 Jun 2025
Last trade
2 Jun 2026
Last filed
13 Jul 2026

Companies traded

Where they are an officer
JUNS Jupiter NeurosciencesDirector, Officer · Biotechnology · last 2 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Jun 2026filed 4 Jun 2026JUNS Jupiter Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—259,231 at $0.00filing
2 Jun 2026filed 4 Jun 2026JUNS Jupiter Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—259,231 at $0.00filing
2 Mar 2026filed 13 Jul 2026JUNS Jupiter NeurosciencesBiotechnologySEC FORM 4 Code M—225,000filing
2 Mar 2026filed 13 Jul 2026JUNS Jupiter Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—225,000 at $0.00filing
2 Mar 2026filed 13 Jul 2026JUNS Jupiter Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—225,000 at $0.00filing
2 Mar 2026filed 13 Jul 2026JUNS Jupiter NeurosciencesBiotechnologySEC FORM 4 Code M—225,000filing
2 Jun 2025filed 13 Jul 2026JUNS Jupiter NeurosciencesBiotechnologySEC FORM 4 Code M—389,793filing
2 Jun 2025filed 13 Jul 2026JUNS Jupiter NeurosciencesBiotechnologySEC FORM 4 Code M—399,402filing
2 Jun 2025filed 13 Jul 2026JUNS Jupiter Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—389,793 at $0.00filing
2 Jun 2025filed 13 Jul 2026JUNS Jupiter Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—399,402 at $0.00filing
2 Jun 2025filed 13 Jul 2026JUNS Jupiter Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—389,793 at $0.00filing
2 Jun 2025filed 13 Jul 2026JUNS Jupiter Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code M—399,402 at $0.00filing
2 Jun 2025filed 13 Jul 2026JUNS Jupiter NeurosciencesBiotechnologySEC FORM 4 Code M—389,793filing
2 Jun 2025filed 13 Jul 2026JUNS Jupiter NeurosciencesBiotechnologySEC FORM 4 Code M—399,402filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Andrew Jon CutlerDirector · Director at Jupiter Neurosciences, filing Form 4 there in the last year
Julie B. KampfDirector · Director at Jupiter Neurosciences, filing Form 4 there in the last year
Nicholas H. HemmerlyDirector · Director at Jupiter Neurosciences, filing Form 4 there in the last year
Holger WeisCEO · Director at Jupiter Neurosciences, filing Form 4 there in the last year
Alexander Gustaf Erik RosenChief Administrative Officer · Chief Administrative Officer at Jupiter Neurosciences, filing Form 4 there in the last year